Atlas Trials

Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia.

Clinical trial NCT05265065 · COMPLETED

Trial details

NCT number
NCT05265065
Sponsor
Murdoch Childrens Research Institute
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2022-05-27
Primary completion
2022-09-30
Enrollment
601

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.